The
global Coronary Artery Bypass Graft (CABG) Market is
expected to reach USD 127.6 million by 2025, according to a new report by Grand
View Research, Inc. The market is expected to witness lucrative growth over the
forecast period, owing to increasing prevalence of Cardiovascular Diseases
(CVDs) such as Coronary Artery Disease (CAD) or Coronary Heart Disease (CHD)
coupled with rising geriatric population across the globe.
Favorable
reimbursement policies, such as the U.S. Medicare (federal health insurance
program) system, Medicaid, and National Health Insurance (NHI) have been a
prime growth factor for the CABG market. Medical device companies provide new
product platforms, which are covered under reimbursement programs that benefit
the patients. Reimbursement services provided by Medicare and other insurers to
physicians and hospitals is expected to fuel the demand for the adoption of
CABG devices such as catheters, cannulae, retractors, positioners &
stabilizers, suction devices, and syringes during the forecast period.
Browse
Details of Report @
http://www.grandviewresearch.com/industry-analysis/coronary-artery-bypass-graft-cabg-market
http://www.grandviewresearch.com/industry-analysis/coronary-artery-bypass-graft-cabg-market
Further Key Findings from the Study Suggest:
- The
saphenous vein grafts segment held a profitable revenue share in 2016 and
is anticipated to grow at a significant rate over the forecast period
- The off-pump
CABG segment is anticipated to witness the fastest growth over the
forecast period owing to the benefits offered by this technology such as
increased safety, effective, reduced chances of bleeding during the surgery,
low chances of stroke, low need for blood transfusions, low injury to the
heart muscle, and improved quality of life
- The
endoscopic vein harvesting segment is expected to gain the market share
over the forecast period as it eliminates the requirement for long
incisions associated with open (conventional) harvesting, resulting in
reducing the risk of wound infection and other complications, minimizing
postoperative pain, and increasing the patient satisfaction level
- North
America is expected to dominate the CABG market during the forecast
period, owing to the rising prevalence of CVDs in the U.S. and Canada. In
addition, increasing per capita healthcare spending and growing population
in the region are expected to spur the growth of this vertical.
- Some of the
key players of this market are Medtronic; TERUMO CORPORATION; Guidant
Group; MAQUET Holding B.V. & Co.KG; Vitalitec International, Inc.;
Novadaq Technologies Inc.; KARL STORZ GmbH & Co. KG; Edwards
Lifesciences; Genesee Biomedical Inc.; and Sorin Group
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
Blog: https://healthcareforecastreport.blogspot.com/
No comments:
Post a Comment